Participate in our spring Move for HOPE for Harvey Campaign-Click Here!

HOPE for Harvey
Home
Harvey's Story
Leadership
Treatment
Events
Donate Today!
HOPE for Harvey
Home
Harvey's Story
Leadership
Treatment
Events
Donate Today!
More
  • Home
  • Harvey's Story
  • Leadership
  • Treatment
  • Events
  • Donate Today!
  • Home
  • Harvey's Story
  • Leadership
  • Treatment
  • Events
  • Donate Today!

Developing a Treatment

On 6/29/22, the Hope for Harvey Foundation signed a contract with Everlum Bio, a rare disease lab who believes that everyone deserves a cure, no matter how big or small the disease. Everlum Bio is based in Austin, TX, and we are excited to partner with them on creating a treatment for DLG4-related Synaptopathy.

Treatment Pathway

We are currently working on these specific tasks with funds from this GoFundMe Campaign and HOPE for Harvey Foundation Fundraising Efforts:  

  • Induced Pluripotent Stem Cells (iPSC) derived neurons ( 3 lines including Harvey's mutation and controls-$33,750)
  • Commercial Line for Quality Control (3 lines at $33,750)
  • Neuronal Differentiation ($14,000)
  • Assay Development and Test for Gain or Loss of Function of PSD-95 for Harvey's mutation ($15,000)
  • RNA Long Read Sequencing ($11,500)
  • Testing drug library of 7,000 small molecules for improvement in Harvey’s cells, including assays ($104,375)
  • Mouse Models (currently have two grant applications being reviewed for our mouse model)
  • 50 Allele-specific Antisense Oligonucleotide (ASO) design and screening ($50,250)
  • Project Management Fee ($18,000)
  • FDA Approval for Clinical Trial (will apply for grant assistance once we have quality pre-clinical data)


Research

Currently there is no treatment options for DLG4-related Synaptopathy.  We hope to change that with your help! 100% of donations will support the development of various treatment modalities. 


Due to advocacy by HOPE for Harvey Foundation, two academic labs recently started research projects on DLG4 Synaptopathy:

  1. The Yu Lab (https://theyulab.org)
  2. Matt Might, as part of the Hugh Kaul Precision Medicine Institute (https://www.uab.edu/medicine/pmi/matt-might)

Francis Collins Urges Gene Therapy Community to Scale Efforts to Tackle Rare Diseases

"Collins concluded by thanking his audience while urging them to do more. 'Of nearly 7,000 genetic disorders, only 500–600 have an FDA-approved therapy,' he said. The goal is to develop therapies for the thousands of disorders for which patients and their families are still waiting in vain."

Read article in Genetic Engineering & Biotechnology News

Rare recessive mutations pry open new windows on autism

"After excluding genetic variants that were also found in the control group and in a separate large cohort of more than 60,000 individuals without autism, Doan, Yu and colleagues were left with 41 genes that were knocked out only in individuals with autism. Overall, the researchers estimate that these genes explain another 3 to 5 percent of all cases of autism (2 percent from loss-of-function mutations, and 1 to 3 percent from missense mutations)."

Read article in EurekaAlert!

Copyright © 2023 HOPE for Harvey Foundation - All Rights Reserved.

  • Home
  • Harvey's Story
  • Leadership
  • Treatment
  • Events

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept